These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 12490852)
1. Activation of the ras/raf-1 signal transduction pathway in carcinoid tumor cells results in morphologic transdifferentiation. Sippel RS; Chen H Surgery; 2002 Dec; 132(6):1035-9; discussion 1039. PubMed ID: 12490852 [TBL] [Abstract][Full Text] [Related]
2. Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells. Sippel RS; Carpenter JE; Kunnimalaiyaan M; Lagerholm S; Chen H Am J Physiol Gastrointest Liver Physiol; 2003 Aug; 285(2):G245-54. PubMed ID: 12851216 [TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor 1 signaling in human gastrointestinal carcinoid tumor cells. Van Gompel JJ; Chen H Surgery; 2004 Dec; 136(6):1297-302. PubMed ID: 15657590 [TBL] [Abstract][Full Text] [Related]
4. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma. Yang R; Piperdi S; Gorlick R Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278 [TBL] [Abstract][Full Text] [Related]
5. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells. Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183 [TBL] [Abstract][Full Text] [Related]
6. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1. Guha S; Lunn JA; Santiskulvong C; Rozengurt E Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255 [TBL] [Abstract][Full Text] [Related]
7. Flagellin and lipopolysaccharide stimulate the MEK-ERK signaling pathway in chicken heterophils through differential activation of the small GTPases, Ras and Rap1. Kogut MH; Genovese KJ; He H Mol Immunol; 2007 Mar; 44(7):1729-36. PubMed ID: 17045653 [TBL] [Abstract][Full Text] [Related]
8. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells. Ulkü AS; Schäfer R; Der CJ Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291 [TBL] [Abstract][Full Text] [Related]
9. B-Raf and C-Raf signaling investigated in a simplified model of the mitogenic kinase cascade. Robubi A; Mueller T; Fueller J; Hekman M; Rapp UR; Dandekar T Biol Chem; 2005 Nov; 386(11):1165-71. PubMed ID: 16307482 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab. Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208 [TBL] [Abstract][Full Text] [Related]
11. Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Schuierer MM; Bataille F; Hagan S; Kolch W; Bosserhoff AK Cancer Res; 2004 Aug; 64(15):5186-92. PubMed ID: 15289323 [TBL] [Abstract][Full Text] [Related]
12. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells. Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520 [TBL] [Abstract][Full Text] [Related]
14. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review). Chang F; Steelman LS; Shelton JG; Lee JT; Navolanic PM; Blalock WL; Franklin R; McCubrey JA Int J Oncol; 2003 Mar; 22(3):469-80. PubMed ID: 12579299 [TBL] [Abstract][Full Text] [Related]
15. Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1. Sasaki A; Taketomi T; Kato R; Saeki K; Nonami A; Sasaki M; Kuriyama M; Saito N; Shibuya M; Yoshimura A Nat Cell Biol; 2003 May; 5(5):427-32. PubMed ID: 12717443 [TBL] [Abstract][Full Text] [Related]
16. The antitumor ether lipid 1-Q-octadecyl-2-O-methyl-rac-glycerophosphocholine (ET-18-OCH3) inhibits the association between Ras and Raf-1. Samadder P; Richards C; Bittman R; Bhullar RP; Arthur G Anticancer Res; 2003; 23(3B):2291-5. PubMed ID: 12894505 [TBL] [Abstract][Full Text] [Related]
17. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2. Lee M Biochem Biophys Res Commun; 2006 Nov; 350(2):450-6. PubMed ID: 17010316 [TBL] [Abstract][Full Text] [Related]
18. ZM336372, a Raf-1 activator, inhibits growth of pheochromocytoma cells. Kappes A; Vaccaro A; Kunnimalaiyaan M; Chen H J Surg Res; 2006 Jun; 133(1):42-5. PubMed ID: 16603190 [TBL] [Abstract][Full Text] [Related]
19. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf. Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118 [TBL] [Abstract][Full Text] [Related]
20. Focal adhesion kinase, a downstream mediator of Raf-1 signaling, suppresses cellular adhesion, migration, and neuroendocrine markers in BON carcinoid cells. Ning L; Chen H; Kunnimalaiyaan M Mol Cancer Res; 2010 May; 8(5):775-82. PubMed ID: 20407018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]